CIP2A Antibody (2G10)


Western Blot: CIP2A Antibody (2G10) [NB110-59722] - Analysis of CIP2A in NIH/3T3 cell lysate.
Immunocytochemistry/ Immunofluorescence: CIP2A Antibody (2G10) [NB110-59722] - CIP2A antibody was tested in U2OS cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight more
Flow Cytometry: CIP2A Antibody (2G10) [NB110-59722] - Intracellular flow cytometric staining of 1 x 10^6 CHO (A) and HEK-293 (B) cells using CIP2A antibody (dark blue). Isotype control shown in orange. An antibody more
Western Blot: CIP2A Antibody (2G10) [NB110-59722] - Detection of CIP2A in HeLa whole cell lysate.

Product Details

Reactivity Hu, Mu, Rt, PmSpecies Glossary
Applications WB, Flow, ICC/IF, IHC, IHC-P
1.8 mg/ml

CIP2A Antibody (2G10) Summary

A synthetic peptide made to a C-terminal portion of the human CIP2A protein. [UniProt# Q8TCG1]
A 300 amino acid portion of the C-terminus.
p90 autoantigen (2G10)
IgG2b Kappa
Protein G purified
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Packaging, Storage & Formulations

Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Tris-glycine, 150mM NaCl
0.05% Sodium Azide
1.8 mg/ml
Protein G purified


Application Notes
This CIP2A antibody is useful for Immunocytochemistry/Immunofluorescence and Western Blot. In ICC/IF, strong cytoplasmic staining is observed in U20s cells. In Western Blot analysis, a band is seen at ~90 kDa representing CIP2A. Use in Immunohistochemistry-Paraffin reported in scientific literature (PMID 25965834)
Read Publications using
NB110-59722 in the following applications:

  • IHC
    3 publications
  • 1 publication
  • WB
    7 publications

Reactivity Notes

Human, mouse, rat and primate. Other species have not been tested.

Alternate Names for CIP2A Antibody (2G10)

  • Cancerous inhibitor of PP2A
  • CIP2A
  • FLJ12850
  • KIAA1524
  • MGC163436
  • p90 autoantigen
  • p90
  • protein CIP2A


Inhibition of protein phosphatase 2A (PP2A) activity has been identified as a prerequisite for the transformation of human cells. The protein, designated Cancerous Inhibitor of PP2A (CIP2A), interacts directly with the oncogenic transcription factor c-Myc, inhibits PP2A activity toward c-Myc serine 62 (S62), and thereby prevents c-Myc proteolytic degradation. In addition to its function in c-Myc stabilization, CIP2A promotes anchorage-independent cell growth and in vivo tumor formation. The oncogenic activity of CIP2A is demonstrated by transformation of human cells by overexpression of CIP2A. Importantly, CIP2A is overexpressed in two common human malignancies, head and neck squamous cell carcinoma (HNSCC) and colon cancer.


This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Customers Who Viewed This Item Also Viewed...

Species: Hu, Mu, Rt
Applications: WB, Simple Western, ICC
Species: Hu, Mu
Applications: WB, ICC/IF, IHC-P, IP
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu, Rt, Ca, Mk
Applications: WB, IHC, IHC-P, IP
Species: Hu, Mu
Applications: WB, ELISA, ICC/IF, IHC, IHC-P, PLA
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu, Mu
Applications: WB, Simple Western
Species: Hu, Mu
Applications: WB, Flow, IHC, ICC
Species: Hu, Mu, Rt
Applications: WB, Simple Western, ICC, ICFlow
Species: Mu, Ec, NA
Applications: WB, ELISA, ICC/IF, IHC-Fr, IP
Species: Hu, Mu, Rt, Bv, Ca, Ch, Xp
Applications: Func-Inh
Species: Hu, Mu, Rt, Pm
Applications: Flow, ICC/IF, IHC, IHC-Fr, IHC-P
Species: Hu
Applications: Flow, Neut
Species: Hu, Mu, Rt, Dr, Rb
Applications: WB, ELISA, ICC/IF, IHC, IHC-Fr, IHC-P, IP, S-ELISA
Species: Hu, Mu, Rt
Applications: WB
Species: Hu, Mu, Rt
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu, Mu, Rt
Applications: WB, Simple Western
Species: Hu
Applications: WB, ICC/IF, IHC, IHC-P

Publications for CIP2A Antibody (NB110-59722)(9)

We have publications tested in 1 confirmed species: Human.

We have publications tested in 3 applications: IHC, IHC-P, WB.

Filter By Application
All Applications
Filter By Species
All Species
Showing Publications 1 - 9 of 9.
Publications using NB110-59722 Applications Species
Khanna A, Rane JK, Kivinummi KK et al. CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations. Oncotarget. 2015 Apr 19 [PMID:25965834] (IHC-P, Human) IHC-P Human
Jung HM, Phillips BL, Chan EK. miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3zeta. Mol. Cancer 2014 Apr 17 [PMID:24708873] (WB, Human) WB Human
Zhai M, Cong L, Han Y et al. CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion. Tumour Biol. 2013 Sep 8 [PMID:24014087]
Jung HM, Patel RS, Phillips BL et al. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions. Mol Biol Cell 2013 Jun [PMID:23552692] (WB, Human) WB Human
Lee J, Jeong H, Park EJ et al. CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression. Rheumatol Int 2013 Mar 2 [PMID:23455633] (WB, Human) WB Human
Ma L, Wen Z-S, Liu Z et al. Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer. PLoS One;6(5):e20159. 2011 [PMID:21655278] (WB, IHC, Human) WB, IHC Human
Lee J, Park EJ, Hwang JW et al. CIP2A expression is associated with synovial hyperplasia and invasive function of fibroblast-like synoviocytes in rheumatoid arthritis Rheumatol Int 2012 Jul [PMID:21479604] (WB, IHC, Human) WB, IHC Human
Wang J, Li W, Li L, Yu X, Jia J, Chen C. CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation. Int J Lab Hematol;33(3):290-8.doi: 10.1111/j.1751-553X.2010.01288.x. 2011 Jun. [PMID:21219591] (WB, Human) WB Human
Li, W et al. CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res;14(12):3722-8. 2008 Jun 15. [PMID:18559589] (WB, IHC, Human) WB, IHC Human

Reviews for CIP2A Antibody (NB110-59722) (0)

There are no reviews for CIP2A Antibody (NB110-59722). By submitting a review earn points towards our Rewards Program.
  • 250 points for product review
  • 500 additional points for an image with your product review
  • Double points (500) if you are the first to review this product
  • Double points (1000) if you are the first to review this product with an image

Product General Protocols

Video Protocols

WB Video Protocol
ICC/IF Video Protocol

FAQs for CIP2A Antibody (NB110-59722) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Positive Control Lysate(s)

Secondary Antibodies


Isotype Controls

Other Available Formats

Alexa Fluor (R) 405 Labeled NB110-59722AF405
Alexa Fluor (R) 488 Labeled NB110-59722AF488
Alexa Fluor (R) 647 Labeled NB110-59722AF647
Alexa Fluor (R) 700 Labeled NB110-59722AF700
Allophycocyanin Labeled NB110-59722APC
Biotin Labeled NB110-59722B
DyLight 350 Labeled NB110-59722UV
DyLight 405 Labeled NB110-59722V
DyLight 405LS Labeled NB110-59722V3
DyLight 488 Labeled NB110-59722G
DyLight 550 Labeled NB110-59722R
DyLight 650 Labeled NB110-59722C
DyLight 680 Labeled NB110-59722FR
DyLight 755 Labeled NB110-59722IR
FITC Labeled NB110-59722F
HRP Labeled NB110-59722H
PE Labeled NB110-59722PE
PerCP Labeled NB110-59722PCP

Additional CIP2A Antibody (2G10) Products

CIP2A NB110-59722

Related Products by Gene

Bioinformatics Tool for CIP2A Antibody (NB110-59722)

Discover related pathways, diseases and genes to CIP2A Antibody (NB110-59722). Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
Visit Tool

Diseases for CIP2A Antibody (NB110-59722)

Discover more about diseases related to CIP2A Antibody (NB110-59722).

Pathways for CIP2A Antibody (NB110-59722)

View related products by pathway.

PTMs for CIP2A Antibody (NB110-59722)

Learn more about PTMs related to CIP2A Antibody (NB110-59722).

Research Areas for CIP2A Antibody (NB110-59722)

Find related products by research area.

Blogs on CIP2A.

CIP2A - A lean, mean, oncoprotein machine
The CIP2A protein was originally identified as p90, a cytoplasmic auto-antigen from the serum of a cancer patient. It was later found to inhibit protein phosphatase 2A (PP2A) activity as well as interact with c-myc. CIP2A's inhibitory activity blocks...  Read full blog post.

CIP2A: The Cancerous Inhibitor of Protein Phosphatase 2A
The autoantigen p90 is a recently discovered protein that binds to and inhibits Protein Phosphatase 2A (PP2A) activity, thereby playing a critical role in cancer progression. Thus, p90 was renamed the "cancerous inhibitory protein of PP2A" or CIP2A....  Read full blog post.

Contact Information

Product PDFs


Gene Symbol KIAA1524

Customer Resources

Novus Review - Submit your review and earn rewards points which can be used for merchandise & discounts.
Risk Free Testing - Test on a species/application not listed above to receive a full credit towards a future purchase.

Novus' Quality Guarantee - Novus guarantees that every product we sell will work in the application and species listed on our website and datasheets.

Submit your question on NB110-59722 below.
During business hours, we will respond to your email within 24 hours. For any questions submitted on the weekend, a response will be received on Monday.
For immediate assistance during business hours M- F (excluding major holidays), please contact us.
Ask a Scientist - We have a lab full of white coats just waiting for your scientific questions and concerns.

Customers Who Bought This Also Bought